The global medical device cleaning market is projected to grow from USD 2.08 billion in 2024 to USD 3.74 billion by 2032, driven by escalating infection prevention requirements, expanding reusable device utilization, and technological advancements in automated reprocessing systems. However, high capital costs, complex regulatory obligations, and workforce training variability pose challenges to uniform adoption across regions.

The global rigid endoscopes market is projected to grow from USD 7.36 billion in 2025 to USD 11.52 billion by 2033, at a CAGR of 5.84%. Growth is driven by technological advancements in HD and 4K imaging, increasing adoption of minimally invasive procedures across multiple surgical specialties, and the rapid expansion of ambulatory surgery centers. North America leads with 41% market share, while Asia-Pacific is expected to register the highest growth rate at 8.00%.

The global fibrin sealant market is projected to grow from USD 1.60 billion in 2025 to USD 3.57 billion by 2035 at a CAGR of 8.37%, driven by increasing surgical volumes, minimally invasive procedures, and expanding applications in trauma and wound care. However, high costs and insurance coverage limitations remain barriers to adoption in emerging markets.

The global uterine fibroid market is projected to grow from USD 5.26 billion in 2025 to USD 9.43 billion by 2033 at a CAGR of 7.63%. Growth is driven by rising prevalence of fibroids (affecting 70-80% of women by age 50), technological advances in minimally invasive procedures with 60% adoption increase, and expanded healthcare infrastructure in emerging markets. Minimally invasive procedures and MRI-guided focused ultrasound are expected to see the fastest growth rates.

The global clinical communication and collaboration market is projected to grow from US$ 2,942.90 million in 2024 to US$ 9,430.65 million by 2033, driven by telemedicine expansion, cloud-based solutions, and wearable medical devices. Hospitals dominate as primary users, while North America leads with over 40% global adoption. Cloud-based solutions captured over 55% of the software deployment market share in 2024.

The global orthopedic implants market is projected to grow from USD 23.50 billion in 2025 to USD 33.20 billion by 2033, expanding at a CAGR of 4.43%. Growth is driven by rising musculoskeletal disorders, aging populations, technological advancements in biomaterials and minimally invasive procedures, and digital orthopedic solutions. However, high implant costs, strict regulatory requirements, and pricing pressures from healthcare providers remain key challenges.

The global surgical staplers market is projected to grow from USD 6.41 billion in 2025 to USD 10.87 billion by 2033, at a CAGR of 6.87%. Growth is driven by increasing surgical volumes, adoption of minimally invasive procedures, and technological advancements in powered and disposable stapling systems. However, high device costs and stringent regulatory requirements pose challenges to market expansion.

Boston Scientific stock plummeted 17.5% on February 4, 2026, despite beating Q4 earnings expectations with 16% sales growth and 14% adjusted EPS growth. The sharp decline was driven by cautious 2026 guidance that fell one penny short of analyst expectations and weaker electrophysiology sales. The analyst argues the market reaction is overdone, citing strong fundamentals including $4.2 billion projected free cash flow for 2026 and 12 consecutive quarters of double-digit sales growth.

Stryker announced a quarterly dividend of $0.88 per share payable April 30, 2026, representing a 4.8% increase compared to the prior year. The company is a global leader in medical technologies serving MedSurg, Neurotechnology, and Orthopaedics sectors, impacting over 150 million patients annually.

The global advanced wound closure market is projected to grow from USD 18.47 billion in 2025 to USD 32.54 billion by 2035, at a CAGR of 6.9%. Growth is driven by increasing surgical procedures, rising chronic wounds and diabetes cases, and technological innovations in surgical sealants, hemostats, and tissue adhesives. North America leads the market while Asia Pacific shows the highest growth potential.

The global orthopedic implants market is valued at USD 52.86 billion in 2026 and is expected to reach USD 80.14 billion by 2034, growing at a 5.34% CAGR. North America leads the market while Asia-Pacific is the fastest-growing region. Joint reconstruction dominates by product type, with spinal implants showing significant growth potential. Key drivers include an aging population, rising musculoskeletal disorders, and technological innovations in 3D-printed and AI-enabled implants.

The global arthroscopy devices market is projected to grow from USD 8.8 billion in 2024 to USD 11.8 billion by 2032, driven by rising incidence of joint disorders, sports injuries, aging populations, and technological advancements in minimally invasive surgical procedures. North America leads the market, with Asia-Pacific expected to witness the fastest growth.